New drug trials for disorders like Down syndrome and Fragile X are presenting researchers with a dilemma: how to make sure people with intellectual disabilities consent to join. Amy Dockser Marcus and... more 
New drug trials for disorders like Down syndrome and Fragile X are presenting researchers with a dilemma: how to make sure people with intellectual disabilities consent to join. Amy Dockser Marcus and Massachusetts General Hospital's Brian Skotko discuss. Photo: Dyer Family. less 
1 / 11
WSJ Live
Tue, Mar 11, 2014 1:25 PM EDT